Solid Biosciences Inc. (SLDB) Market Cap
- 2026-09-03: Market Cap $1.12B.
- 2026-08-04: Market Cap $924.28M.
- 2026-06-30: Market Cap $1.05B.
- 2026-05-08: Market Cap $715.73M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2018-03-31 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|
| 2026-09-03 | $1.12B |
|---|
| 2026-08-04 | $924.28M |
|---|
| 2026-06-30 | $1.05B |
|---|
| 2026-05-08 | $715.73M |
|---|
| 2026-03-31 | $708.44M |
|---|
| 2026-03-16 | $735.97M |
|---|
| 2025-12-31 | $445.38M |
|---|
| 2025-10-29 | $427.73M |
|---|
| 2025-09-30 | $480.54M |
|---|
| 2025-08-07 | $482.01M |
|---|
| 2025-06-30 | $377.93M |
|---|
| 2025-05-12 | $224.79M |
|---|
| 2025-03-31 | $286.72M |
|---|
| 2025-03-03 | $396.76M |
|---|
| 2024-12-31 | $161.87M |
|---|
| 2024-11-01 | $229.74M |
|---|
| 2024-09-30 | $271.34M |
|---|
| 2024-08-09 | $284.83M |
|---|
| 2024-06-30 | $218.58M |
|---|
| 2024-05-10 | $398.76M |
|---|
| 2024-03-31 | $503.94M |
|---|
| 2024-03-05 | $358.69M |
|---|
| 2023-12-31 | $125.17M |
|---|
| 2023-11-06 | $55.49M |
|---|
| 2023-09-30 | $50.56M |
|---|
| 2023-08-08 | $77.03M |
|---|
| 2023-06-30 | $105.03M |
|---|
| 2023-05-07 | $104.87M |
|---|
| 2023-03-31 | $92.78M |
|---|
| 2023-03-20 | $72.03M |
|---|
| 2022-12-31 | $105.22M |
|---|
| 2022-11-04 | $46.04M |
|---|
| 2022-09-30 | $52.77M |
|---|
| 2022-08-08 | $1.27B |
|---|
| 2022-06-30 | $1.04B |
|---|
| 2022-04-22 | $1.37B |
|---|
| 2022-03-31 | $2.03B |
|---|
| 2022-02-16 | $1.74B |
|---|
| 2021-12-31 | $193.1M |
|---|
| 2021-11-01 | $3.54B |
|---|
| 2021-09-30 | $3.95B |
|---|
| 2021-08-10 | $4.38B |
|---|
| 2021-06-30 | $6.06B |
|---|
| 2021-05-10 | $7.64B |
|---|
| 2021-03-31 | $9.15B |
|---|
| 2021-02-16 | $9.26B |
|---|
| 2020-12-31 | $9.65B |
|---|
| 2020-11-01 | $2.97B |
|---|
| 2020-09-30 | $1.41B |
|---|
| 2020-08-01 | $1.82B |
|---|
| 2020-06-30 | $2.02B |
|---|
| 2020-05-01 | $1.61B |
|---|
| 2020-03-31 | $1.65B |
|---|
| 2020-02-15 | $2.19B |
|---|
| 2019-12-31 | $3.07B |
|---|
| 2019-11-01 | $7.95B |
|---|
| 2019-09-30 | $7.13B |
|---|
| 2019-08-01 | $3.77B |
|---|
| 2019-06-30 | $3.05B |
|---|
| 2019-05-01 | $5.05B |
|---|
| 2019-03-31 | $4.89B |
|---|
| 2019-02-15 | $4.24B |
|---|
| 2018-12-31 | $14.24B |
|---|
| 2018-11-01 | $18.66B |
|---|
| 2018-09-30 | $25.08B |
|---|
| 2018-08-01 | $21.55B |
|---|
| 2018-06-30 | $18.94B |
|---|
| 2018-05-01 | $7.8B |
|---|
| 2018-03-31 | $3.99B |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
|---|
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
|---|
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
|---|